Hint mode is switched on Switch off

I-MAB Biopharma, American depositary receipt (ADR)
US44975P1030, IMAB

Add a stock to WL
Choose all Reset all
I-MAB Biopharma, сountry — China
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

Profile
I-MAB Biopharma Co., Ltd. develops and manufacture pharmaceutical products. The Company produces monoclonal antibodies, immune cytokines, bispecific antibodies, tumor innovative drugs, and other products. I-MAB Biopharma markets its products throughout China.
  • Issuer
  • Full borrower / issuer name
    I-MAB Biopharma Co Ltd
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IMAB
  • Placement
    17.01.2020
  • Lock up period
    180
  • Number of papers
    7,407,400
  • Volume of raised funds
    103.7 mln USD
  • Placement share
    100%
  • Final placement price
    14 USD
  • Price change since placement date
    -87.14%
  • By capitalization
    103.7 mln USD

IFRS/US GAAP reports

2022
IV q eng
2021
IV q eng
2020
IV q eng
2019
IV q eng
Show all Hide
Authorization required
You need to request access

Related Stock indices

Indicators

Holders

Industry Leaders

Registration is required to get access.